Literature DB >> 24096033

Accelerated recovery of renal mitochondrial and tubule homeostasis with SIRT1/PGC-1α activation following ischemia-reperfusion injury.

Jason A Funk1, Rick G Schnellmann.   

Abstract

Kidney ischemia-reperfusion (I/R) injury elicits cellular injury in the proximal tubule, and mitochondrial dysfunction is a pathological consequence of I/R. Promoting mitochondrial biogenesis (MB) as a repair mechanism after injury may offer a unique strategy to restore both mitochondrial and organ function. Rats subjected to bilateral renal pedicle ligation for 22 min were treated once daily with the SIRT1 activator SRT1720 (5mg/kg) starting 24h after reperfusion until 72h-144 h. SIRT1 expression was elevated in the renal cortex of rats after I/R+vehicle treatment (IRV), but was associated with less nuclear localization. SIRT1 expression was even further augmented and nuclear localization was restored in the kidneys of rats after I/R+SRT1720 treatment (IRS). PGC-1α was elevated at 72 h-144 h in IRV and IRS kidneys; however, SRT1720 treatment induced deacetylation of PGC-1α, a marker of activation. Mitochondrial proteins ATP synthase β, COX I, and NDUFB8, as well as mitochondrial respiration, were diminished 24h-144 h in IRV rats, but were partially or fully restored in IRS rats. Urinary kidney injury molecule-1 (KIM-1) was persistently elevated in both IRV and IRS rats; however, KIM-1 tissue expression was attenuated in IRS rats. Additionally, sustained loss of Na(+),K(+)-ATPase expression and basolateral localization and elevated vimentin in IRV rats was normalized in IRS rats, suggesting restoration of a differentiated, polarized tubule epithelium. The results suggest that SRT1720 treatment expedited recovery of mitochondrial protein expression and function by enhancing MB, which was associated with faster proximal tubule repair. Targeting MB may offer unique therapeutic strategy following ischemic injury.
© 2013. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATP synthase subunit β; ATPβ; Acute kidney injury; COX I; Drp1; Ischemia–reperfusion; KIM-1; Mfn2; Mitochondrial biogenesis; Mitochondrial dysfunction; NADH dehydrogenase (ubiquinone) 1 beta subcomplex 8; NDUFB8; PGC-1α; Proximal tubule; SIRT1; SRT1720; cytochrome c oxidase subunit I; dynamin related protein 1; kidney injury molecule 1; mitofusin-2; peroxisome proliferator activated receptor γ coactivator-1α; sCr; serum creatinine; sirtuin 1

Mesh:

Substances:

Year:  2013        PMID: 24096033      PMCID: PMC3987743          DOI: 10.1016/j.taap.2013.09.026

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  43 in total

1.  Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation.

Authors:  Jérôme N Feige; Marie Lagouge; Carles Canto; Axelle Strehle; Sander M Houten; Jill C Milne; Philip D Lambert; Chikage Mataki; Peter J Elliott; Johan Auwerx
Journal:  Cell Metab       Date:  2008-11       Impact factor: 27.287

Review 2.  PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure.

Authors:  Carles Cantó; Johan Auwerx
Journal:  Curr Opin Lipidol       Date:  2009-04       Impact factor: 4.776

3.  Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery.

Authors:  Won K Han; Gebhard Wagener; Yanqing Zhu; Shuang Wang; H Thomas Lee
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 8.237

4.  5-hydroxytryptamine receptor stimulation of mitochondrial biogenesis.

Authors:  Kyle A Rasbach; Jason A Funk; Tamilselvan Jayavelu; Peter T Green; Rick G Schnellmann
Journal:  J Pharmacol Exp Ther       Date:  2009-10-29       Impact factor: 4.030

5.  AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity.

Authors:  Carles Cantó; Zachary Gerhart-Hines; Jerome N Feige; Marie Lagouge; Lilia Noriega; Jill C Milne; Peter J Elliott; Pere Puigserver; Johan Auwerx
Journal:  Nature       Date:  2009-04-23       Impact factor: 49.962

6.  Expression and function of the Delta-1/Notch-2/Hes-1 pathway during experimental acute kidney injury.

Authors:  T Kobayashi; Y Terada; H Kuwana; H Tanaka; T Okado; M Kuwahara; S Tohda; S Sakano; S Sasaki
Journal:  Kidney Int       Date:  2008-04-16       Impact factor: 10.612

7.  Suramin promotes recovery from renal ischemia/reperfusion injury in mice.

Authors:  Shougang Zhuang; Bo Lu; Rebecca A Daubert; Kenneth D Chavin; Liquan Wang; Rick G Schnellmann
Journal:  Kidney Int       Date:  2008-10-08       Impact factor: 10.612

8.  Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models.

Authors:  Craig Brooks; Qingqing Wei; Sung-Gyu Cho; Zheng Dong
Journal:  J Clin Invest       Date:  2009-04-06       Impact factor: 14.808

9.  Isoflavones promote mitochondrial biogenesis.

Authors:  Kyle A Rasbach; Rick G Schnellmann
Journal:  J Pharmacol Exp Ther       Date:  2008-02-11       Impact factor: 4.030

10.  Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo.

Authors:  Jesse J Smith; Renée Deehan Kenney; David J Gagne; Brian P Frushour; William Ladd; Heidi L Galonek; Kristine Israelian; Jeffrey Song; Giedre Razvadauskaite; Amy V Lynch; David P Carney; Robin J Johnson; Siva Lavu; Andre Iffland; Peter J Elliott; Philip D Lambert; Keith O Elliston; Michael R Jirousek; Jill C Milne; Olivier Boss
Journal:  BMC Syst Biol       Date:  2009-03-10
View more
  63 in total

Review 1.  Targeting Endogenous Repair Pathways after AKI.

Authors:  Benjamin D Humphreys; Vincenzo Cantaluppi; Didier Portilla; Kai Singbartl; Li Yang; Mitchell H Rosner; John A Kellum; Claudio Ronco
Journal:  J Am Soc Nephrol       Date:  2015-11-18       Impact factor: 10.121

Review 2.  Cellular and Molecular Mechanisms of AKI.

Authors:  Anupam Agarwal; Zheng Dong; Raymond Harris; Patrick Murray; Samir M Parikh; Mitchell H Rosner; John A Kellum; Claudio Ronco
Journal:  J Am Soc Nephrol       Date:  2016-02-09       Impact factor: 10.121

3.  Urinary ATP Synthase Subunit β Is a Novel Biomarker of Renal Mitochondrial Dysfunction in Acute Kidney Injury.

Authors:  Ryan M Whitaker; Midhun C Korrapati; Lindsey J Stallons; Sean R Jesinkey; John M Arthur; Craig C Beeson; Zhi Zhong; Rick G Schnellmann
Journal:  Toxicol Sci       Date:  2015-02-09       Impact factor: 4.849

4.  Extracellular signal-regulated kinase 1/2 regulates NAD metabolism during acute kidney injury through microRNA-34a-mediated NAMPT expression.

Authors:  Justin B Collier; Rick G Schnellmann
Journal:  Cell Mol Life Sci       Date:  2019-12-23       Impact factor: 9.261

Review 5.  Renoprotective approaches and strategies in acute kidney injury.

Authors:  Yuan Yang; Meifang Song; Yu Liu; Hong Liu; Lin Sun; Youming Peng; Fuyou Liu; Manjeri A Venkatachalam; Zheng Dong
Journal:  Pharmacol Ther       Date:  2016-04-22       Impact factor: 12.310

Review 6.  Recent advances in acute kidney injury and its consequences and impact on chronic kidney disease.

Authors:  Anna Zuk; Joseph V Bonventre
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-07       Impact factor: 2.894

7.  Agonism of the 5-hydroxytryptamine 1F receptor promotes mitochondrial biogenesis and recovery from acute kidney injury.

Authors:  Sara M Garrett; Ryan M Whitaker; Craig C Beeson; Rick G Schnellmann
Journal:  J Pharmacol Exp Ther       Date:  2014-05-21       Impact factor: 4.030

8.  5-hydroxytryptamine 1F Receptor Agonist Induces Mitochondrial Biogenesis and Promotes Recovery from Spinal Cord Injury.

Authors:  Epiphani C Simmons; Natalie E Scholpa; Kristan H Cleveland; Rick G Schnellmann
Journal:  J Pharmacol Exp Ther       Date:  2019-11-27       Impact factor: 4.030

Review 9.  Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases.

Authors:  Robert B Cameron; Craig C Beeson; Rick G Schnellmann
Journal:  J Med Chem       Date:  2016-09-27       Impact factor: 7.446

10.  Pharmacological Stimulation of Mitochondrial Biogenesis Using the Food and Drug Administration-Approved β2-Adrenoreceptor Agonist Formoterol for the Treatment of Spinal Cord Injury.

Authors:  Natalie E Scholpa; Hannah Williams; Wenxue Wang; Daniel Corum; Aarti Narang; Stephen Tomlinson; Patrick G Sullivan; Alexander G Rabchevsky; Rick G Schnellmann
Journal:  J Neurotrauma       Date:  2018-11-16       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.